Literature DB >> 9468258

Oral budesonide for lymphocytic colitis.

A Van Gossum1, A Schmit, M O Peny.   

Abstract

Lymphocytic colitis is a rare inflammatory colonic disease of unknown etiology accompanied by watery diarrhea. Diagnosis is based upon pathological examination of colonic biopsies. Treatment essentially involves antiinflammatory agents such as sulfasalazine/5-ASA or corticosteroids if necessary. We report the case of a female patient suffering from severe lymphocytic colitis who remained unresponsive after 5-ASA therapy but who improved dramatically after oral budesonide administration.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9468258     DOI: 10.1111/j.1572-0241.1998.270_1.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  6 in total

1.  Lymphocytic and Collagenous Colitis: Medical Management.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-04

2.  Pharmacokinetic/pharmacodynamic modeling of total lymphocytes and selected subtypes after oral budesonide.

Authors:  Jeffrey G Stark; Sybille Werner; Susanne Homrighausen; Yufei Tang; Michael Krieg; Hartmut Derendorf; Helmut Moellmann; Guenther Hochhaus
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-04-22       Impact factor: 2.745

3.  Noninfectious colitides: collagenous colitis, lymphocytic colitis, diversion colitis, and chemically induced colitis.

Authors:  Amy J Thorsen
Journal:  Clin Colon Rectal Surg       Date:  2007-02

Review 4.  Interventions for treating lymphocytic colitis.

Authors:  Nilesh Chande; Noor Al Yatama; Tania Bhanji; Tran M Nguyen; John Wd McDonald; John K MacDonald
Journal:  Cochrane Database Syst Rev       Date:  2017-07-13

5.  BUDESONIDE-INDUCED HYPEROSMOLAR HYPERGLYCEMIC STATE FOLLOWING TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT.

Authors:  Thejus Jayakrishnan; Meera Babu; Steven Goodnow; Brent Hardman
Journal:  AACE Clin Case Rep       Date:  2020-09-21

6.  Pharmacokinetic/pharmacodynamic modeling of corticosterone suppression and lymphocytopenia by methylprednisolone in rats.

Authors:  Zhenling Yao; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  J Pharm Sci       Date:  2008-07       Impact factor: 3.534

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.